PTK2 and breast carcinoma: We cannot exclude that PRLR signaling is still capable of promoting breast cancer progression and invasion through Jak2/Stat5-independent pathways such as c-Src, FAK, and MAP kinases and beyond towards proliferative effects; thus, other PLR roles are currently being diligently investigated.